Travis Steed
Stock Analyst at B of A Securities
(0.26)
# 2039
Out of 5,240 analysts
90
Total ratings
43.10%
Success rate
7.03%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Edwards Lifesciences | Upgrades: Buy | 82 90 | 71.86 | 25.24% | 4 | Dec 16, 2024 | |
CeriBell | Initiates Coverage On: Buy | 32 | 20.67 | 54.81% | 1 | Nov 5, 2024 | |
Solventum | Maintains: Neutral | 70 60 | 71.68 | -16.29% | 2 | Jun 25, 2024 | |
Becton Dickinson | Maintains: Overweight | 305 312 | 237.41 | 31.42% | 6 | May 6, 2024 | |
Baxter Intl | Maintains: Neutral | 42 45 | 30.73 | 46.44% | 5 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 32 3 | 0.79 | 279.75% | 1 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 315 | 367.45 | -14.27% | 4 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 365 295 | 269.13 | 9.61% | 3 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 | 18.03 | -11.26% | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 51 28 | n/a | n/a | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 45 33 | 36.65 | -9.96% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 120 160 | 104.73 | 52.77% | 11 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 300 315 | 569.99 | -44.74% | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 335 275 | n/a | n/a | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 8 | 6.77 | 18.17% | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 25 | 20.15 | 24.07% | 1 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 140 | 112.21 | 24.77% | 4 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 85 | 16.54 | 413.91% | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 74 | n/a | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 125 | 81.78 | 52.85% | 7 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | n/a | n/a | n/a | 1 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 145 | 85.65 | 69.29% | 1 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 51 | 97.07 | -47.46% | 6 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 175 | 67.56 | 159.03% | 4 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 6 | n/a | n/a | 2 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 59 54 | 22.35 | 141.61% | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 22 | 94.43 | -76.7% | 1 | Jul 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 86 | n/a | n/a | 1 | Jun 30, 2017 |